We are live on ! Find out more
CCM

Catapult Capital Management Portfolio holdings

AUM $265M
1-Year Est. Return 21.83%
This Fund
S&P 500
This Quarter Est. Return
+5.74%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$696M
AUM Growth
-$122M
Cap. Flow
-$135M
Cap. Flow %
-19.45%
Top 10 Hldgs %
23.76%
Holding
329
New
119
Increased
34
Reduced
64
Closed
111

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$23.2M
2
PEP icon
PepsiCo
PEP
+$13.1M
3
ABBV icon
AbbVie
ABBV
+$10.1M
4
ELV icon
Elevance Health
ELV
+$9.59M
5
ABT icon
Abbott
ABT
+$8.4M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$22.4M
2
PFE icon
Pfizer
PFE
+$18M
3
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$13.1M
4
MD icon
Pediatrix Medical
MD
+$11.2M
5
DHR icon
Danaher
DHR
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 42.68%
2 Consumer Discretionary 8.46%
3 Industrials 7.26%
4 Consumer Staples 5.08%
5 Communication Services 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QLIK
326
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
– –
-20,182
Closed -$628K
FNSR
327
CALL
DELISTED
Finisar Corp
FNSR
– –
-100,000
Closed -$2.13M
FNSR
328
DELISTED
Finisar Corp
FNSR
– –
-28,016
Closed -$598K
SWFT
329
DELISTED
Swift Transportation Company
SWFT
– –
-12,007
Closed -$312K
10 11 12 13
14

Similar funds

LOCB
Lombard Odier & Cie (Bahamas) Nassau, Bahamas $263M AUM 3.37% 1-Year Est. Return
AF
Adirondack Funds Guilderland, New York $261M AUM
TCOTO
Trust Company of the Ozarks Springfield, Missouri $290M AUM 12.7% 1-Year Est. Return
DCM
Dinsmore Capital Management Morristown, New Jersey $230M AUM 0.29% 1-Year Est. Return
SCA
Samson Capital Advisors New York $228M AUM 0.84% 1-Year Est. Return
LPVHS
Lexington Partners VI Holdings Sub New York $227M AUM 24.75% 1-Year Est. Return
ATC
Argent Trust Company Ruston, Louisiana $225M AUM 5.44% 1-Year Est. Return
TFF
Timothy F. Fidgeon $203M AUM 2.36% 1-Year Est. Return

Catapult Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Catapult Capital Management held 329 positions worth $696M, down 15% from $818M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Catapult Capital Management withdrew a net $135M in Q2 2015, closing 111 positions and reducing 64 holdings. Its most notable exit was Pfizer, an estimated $18M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Catapult Capital Management opened a new position in Zoetis worth $23.5M.

  • Catapult Capital Management's largest Q2 2015 buy was Zoetis: 486,665 shares worth $23.5M.
  • Catapult Capital Management added most to AbbVie in Q2 2015, an estimated $10.1M increase.
  • Catapult Capital Management's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $22.4M.
  • Catapult Capital Management fully exited Pfizer in Q2 2015, selling an estimated $18M.
  • Catapult Capital Management's ten largest holdings make up 24% of its $696M portfolio in Q2 2015.
  • Catapult Capital Management opened 119 new positions and closed 111 in Q2 2015.
  • Catapult Capital Management's portfolio value fell 15% quarter-over-quarter to $696M.

Based on Catapult Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.